# Effect of Neurofast® Supplementation on Anxiety and Cardiovascular Outcomes in the Psycho-Cardio Phenotype Adults

> **NCT07502807** · NA · NOT_YET_RECRUITING · sponsor: **Liaquat University of Medical & Health Sciences** · enrollment: 80 (estimated)

## Conditions studied

- Anxiety
- Cardiovascular Diseases

## Interventions

- **DIETARY_SUPPLEMENT:** Neurofast® supplement

## Key facts

- **NCT ID:** NCT07502807
- **Lead sponsor:** Liaquat University of Medical & Health Sciences
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-07
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-03-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07502807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07502807, "Effect of Neurofast® Supplementation on Anxiety and Cardiovascular Outcomes in the Psycho-Cardio Phenotype Adults". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07502807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*